Answer
Topical betamethasone valerate in Betnovate Cream reduces inflammation by inhibiting late-phase allergic reactions through reduced mast-cell density, reduced eosinophil chemotaxis and activation, decreased cytokine production by lymphocytes, monocytes, mast cells and eosinophils, and inhibition of arachidonic acid metabolism.
Sources for this answer
- Betnovate CreamGlaxoSmithKline UK · emc · SmPC §5.1 Pharmacodynamic properties · Version 19Document updated
Sources checked